How to Develop a Practical (and Compliant) Vendor Qualification Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

How to Develop a Practical (and Compliant) Vendor Qualification Program
This article introduces the "Q.U.E.S.T." approach for vendor qualification, a practical and compliant methodology for pharmaceutical and biopharmaceutical companies to qualify vendors and hence make well-informed purchasing-related decisions.


Pharmaceutical Technology
Volume 33, Issue 10

E = Evaluation Phase: Identification of the best potential vendor

Now that at least three vendors have been identified to meet the company's requirements, it is time for vendor evaluation. First, each vendor is assessed against the company requirements as specified in the Question Phase. All of the potential vendors previously identified will be able to meet each and every requirement specified—vendors that could not meet the requirements have already been eliminated. This evaluation pertains to how well each vendor meets each requirement when compared to the other short-listed vendors. The format of this evaluation can be as simple as a table with columns for the vendor and for the requirements where a simple rating system is applied to each requirement for each vendor.


Table I: Example API vendor evaluation.
An example of such a table for the evaluation of an active pharmaceutical ingredient (API) supplier is shown in Table I. Once the ratings are assigned, a simple average can be used to determine the best overall option. Keep in mind that this is not the final step in the process. The Evaluation Phase has only identified and documented the best potential vendor.

S = Site Audit Phase: Onsite and offsite verifications


Table II: Example vendor type criticality assignment.
The next-to-last phase in the vendor qualification process involves a site audit of the potential vendor's facility. As the cost of an audit is a potentially pricey activity, the site audit maybe performed onsite or offsite depending on the criticality of the potential vendor type and is limited to the best potential vendor identified in the Evaluation Phase. Vendor types need to be divided into critical and noncritical suppliers. A critical vendor is one that supplies goods or services that directly controls or dictates the quality and integrity of pharmaceutical and biopharmaceutical products. A noncritical vendor is one that supplies goods or services that assist and support the quality of these products. As the interpretation of the definitions of critical and noncritical suppliers varies among companies, it is imperative that an approved and controlled company document (or documents) clearly defines which vendor types are deemed critical and which are deemed as non-critical. Examples of critical and noncritical vendor types are listed in Table III.


Table III: Example onsite verification form – contract packaging facility.
If the best potential vendor identified in the Evaluation Phase is a potential critical vendor, it is highly recommended that this vendor be subjected to an onsite audit with predetermined (i.e., documented and approved) items requiring onsite verification. The onsite audit procedure should contain clear pass/fail criteria for the onsite vendor audit. An example portion of a form to be completed during the onsite verification for a contract packager is shown in Table III.


Table IV: Example offsite audit checklist – calibration contractor.
If the best potential vendor identified in the Evaluation Phase is a potential noncritical vendor, the vendor should be subjected to an offsite audit with a separate predetermined (i.e. documented and approved) audit checklist containing predetermined pass/fail criteria for the overall audit. While the verifications maybe similar to that of an onsite audit, the offsite audit relies on verbal discussions, emails, and documentation provided by the potential vendor to determine acceptability of the vendor's practices and quality systems. An example portion of a checklist for an offsite audit for a calibration contractor is shown in Table IV.

Based upon the overall score for both onsite and offsite audits, a potential vendor is either accepted or rejected. If accepted, the vendor is considered qualified. If rejected, the company can either work with the vendor to address the deficiencies and perform a verification audit at a later date (but prior to using the vendor or considering the vendor qualified), or select another potential vendor identified during the Evaluation Phase and subject that vendor to the Site Audit Phase.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here